首页> 美国卫生研究院文献>Scientific Reports >Trans-spliced Cas9 allows cleavage of HBB and CCR5 genes in human cells using compact expression cassettes
【2h】

Trans-spliced Cas9 allows cleavage of HBB and CCR5 genes in human cells using compact expression cassettes

机译:反式Cas9允许使用紧凑型表达盒切割人类细胞中的HBB和CCR5基因

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

CRISPR/Cas9 systems have been used in a wide variety of biological studies; however, the large size of CRISPR/Cas9 presents challenges in packaging it within adeno-associated viruses (AAVs) for clinical applications. We identified a two-cassette system expressing pieces of the S. pyogenes Cas9 (SpCas9) protein which splice together in cellula to form a functional protein capable of site-specific DNA cleavage. With specific CRISPR guide strands, we demonstrated the efficacy of this system in cleaving the HBB and CCR5 genes in human HEK-293T cells as a single Cas9 and as a pair of Cas9 nickases. The trans-spliced SpCas9 (tsSpCas9) displayed ~35% of the nuclease activity compared with the wild-type SpCas9 (wtSpCas9) at standard transfection doses, but had substantially decreased activity at lower dosing levels. The greatly reduced open reading frame length of the tsSpCas9 relative to wtSpCas9 potentially allows for more complex and longer genetic elements to be packaged into an AAV vector including tissue-specific promoters, multiplexed guide RNA expression, and effector domain fusions to SpCas9. For unknown reasons, the tsSpCas9 system did not work in all cell types tested. The use of protein trans-splicing may help facilitate exciting new avenues of research and therapeutic applications through AAV-based delivery of CRISPR/Cas9 systems.
机译:CRISPR / Cas9系统已用于多种生物学研究中。但是,CRISPR / Cas9的大尺寸在将其包装在腺相关病毒(AAV)中以进行临床应用方面带来了挑战。我们确定了两个盒式系统,表达化脓性链球菌Cas9(SpCas9)蛋白片断,它们在纤维素中剪接在一起以形成能够进行位点特异性DNA切割的功能蛋白。使用特定的CRISPR引导链,我们证明了该系统在切割人HEK-293T细胞中的HBB和CCR5基因上作为单个Cas9和一对Cas9切口酶的功效。在标准转染剂量下,与野生型SpCas9(wtSpCas9)相比,反剪的SpCas9(tsSpCas9)展示了约35%的核酸酶活性,但在较低剂量水平下其活性却大大降低。相对于wtSpCas9,tsSpCas9的开放阅读框长度大大减少,可能允许将更复杂和更长的遗传元件包装到AAV载体中,包括组织特异性启动子,多重指导RNA表达以及与SpCas9融合的效应子结构域。由于未知原因,tsSpCas9系统无法在所有测试的细胞类型中正常工作。通过基于AAV的CRISPR / Cas9系统交付,蛋白转拼的使用可能有助于促进激动人心的研究和治疗应用的新途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号